How Do I Manage Audit Trails in Pharma Manufacturing?

You manage audit trails in pharma manufacturing by deciding which records are critical, configuring software to capture changes properly, restricting access, training users, reviewing exceptions, and keeping the audit trail connected to the company’s quality system.

Audit trails are not just technical logs. In pharma, they help protect trust in digital records. They show who performed an action, when it happened, and what changed. When implemented well, they support accountability, investigation, and review.

But audit trails only work when the surrounding process is disciplined. If everyone shares passwords, if too many users have admin rights, or if corrections happen informally outside the system, the audit trail becomes weak.

AICAN Optiwise helps manufacturers bring key workflows into ERP so important activities in inventory, production, quality, purchase, sales, and finance can be managed with better visibility.

Decide what needs audit trail control

Not every screen in a system has the same risk. Start by identifying records that affect product quality, batch traceability, financial accuracy, inventory control, or regulatory documentation.

In pharma manufacturing, audit trail attention is commonly needed for:

• Item masters
• Vendor masters
• BOMs or formulas
• Batch records
• Material receipts
• Quality inspection records
• Stock status changes
• Production consumption
• Finished goods release
• Rejections and holds
• Corrections and reversals
• User access changes

The company’s quality team should help define which records are critical based on SOPs and applicable regulatory expectations.

Capture the right audit trail details

A useful audit trail should answer basic questions quickly.

It should show:

• Who made the change?
• When was it made?
• What record was changed?
• What was the old value?
• What is the new value?
• Was a reason required?
• Was approval required?
• Was the action part of a correction or reversal?

If the audit trail only says "record updated" without meaningful detail, it may not be useful for review. The system should give enough context for quality and management teams to understand what happened.

Use individual user accounts

Audit trails are only reliable when user identity is reliable. Shared logins weaken accountability.

Each user should have an individual account. Password policies, access reviews, and user deactivation processes should also be defined.

For example:

• A storekeeper receives material under their own login.
• A quality user approves or rejects material under their own login.
• A production supervisor records batch output under their own login.
• An authorized user performs correction with reason capture.

This makes the record trail clearer and reduces disputes later.

Restrict admin access

Too many admin users create risk. Admin access should be limited, documented, and reviewed.

Admin users may be able to change masters, permissions, workflows, or system settings. In a pharma environment, this power should not be casual.

Good practice includes:

• Defining admin roles clearly
• Limiting admin rights to trained authorized users
• Reviewing user access periodically
• Removing access when employees change roles or leave
• Keeping configuration changes documented
• Avoiding generic shared admin accounts

Access control and audit trail management work together. One without the other is not enough.

Build reason capture for critical changes

Some changes need a reason. For example, changing a batch quantity, reversing a stock movement, modifying a quality status, or editing a master record may require explanation.

Reason capture helps future reviewers understand why the change happened. It also encourages users to think before making corrections.

Not every minor action needs heavy approval, but critical changes should not be silent.

Review audit trails, do not just store them

A common mistake is assuming that having an audit trail is enough. If nobody reviews it, important exceptions may go unnoticed.

Companies should define review practices based on risk.

Review may focus on:

• Master data changes
• Quality status changes
• Backdated entries
• Deleted or reversed transactions
• Repeated corrections
• Changes made outside normal working patterns
• User access changes
• Failed login patterns where relevant

The review frequency and responsibility should be defined by the company’s quality system.

Connect audit trails with SOPs and training

Users should understand that audit trails are not punishment tools. They are part of record integrity.

Training should explain:

• Why individual logins matter
• Which actions are recorded
• When a reason is required
• How corrections should be made
• What not to do outside the system
• Why sharing passwords is unacceptable
• How audit trail review supports quality discipline

When users understand the purpose, adoption improves.

Avoid common audit trail failures

Pharma manufacturers should watch for these weaknesses:

• Shared user IDs
• Admin access given too broadly
• Critical changes without old and new values
• Corrections made outside ERP
• Quality decisions recorded in spreadsheets only
• Audit trails that cannot be reviewed easily
• No periodic access review
• No reason capture for major changes
• No SOP explaining digital record handling

These gaps can reduce trust in the system.

Where Optiwise fits

Optiwise can help manufacturers structure operational records across inventory, production, quality checkpoints, purchase, sales, finance, and reporting.

For audit trail discipline, a practical ERP implementation should focus on:

• Role-based access
• User accountability
• Controlled master data changes
• Batch-wise transaction records
• Quality status visibility
• Correction workflows
• Management reports

AICAN supports manufacturers in building ERP around real operational control, not just transaction entry.

Founder’s Note

An audit trail is most useful when it tells the truth without drama. It should help a plant understand what changed, who changed it, and why. At AICAN, we believe digital records should reduce argument and increase clarity. When the system is configured properly and users are trained well, audit trails become part of everyday discipline. Learn more at About AICAN.

FAQs

How do I manage audit trails in pharma manufacturing?

Identify critical records, use individual logins, restrict access, configure audit trail capture, require reasons for critical changes, review exceptions, train users, and align the process with SOPs and applicable regulatory expectations.

What should an audit trail show?

It should show user identity, timestamp, record changed, old value, new value, action performed, and reason or approval where required.

Are shared logins acceptable for audit trails?

Shared logins weaken accountability and should be avoided. Individual user accounts are important for reliable audit trails.

Should audit trails be reviewed regularly?

Yes. Audit trails should be reviewed based on risk. Critical changes, reversals, master edits, quality status changes, and access changes deserve attention.

Can ERP support pharma audit trail requirements?

A properly configured ERP can support audit trail discipline for key manufacturing records. Final requirements depend on the company’s quality system and applicable regulations.